About
Assembly Biosciences develops novel therapies targeting serious viral and liver diseases including recurrent genital herpes, chronic hepatitis B and D, and cholestatic liver diseases.
Explore Assembly Biosciences's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.